SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR

This invention relates to sustained release dosage forms comprising {f-1-[3 fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-y1-3- [4-(7H-pyrrolo[2,3 d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto....

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	YELESWARAM, Krishnaswamy, PARIKH, Bhavnish, MODI, Dilip P, SHETH, Trupti
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!